WESTROCK — Naproxen Importer Profile
Pharmaceutical Importer · #14 buyer for Naproxen · $1.5M import value · 33 shipments · UNITED STATES · DGFT Verified
WESTROCK is the #14 importer of Naproxen from India with $1.5M in import value and 33 verified shipments. WESTROCK holds a 1.2% market share in Naproxen imports based in UNITED STATES. The company sources from 3 verified suppliers across 19 formulations shipped to 2 countries.
WESTROCK — Naproxen Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Naproxen to WESTROCK?
Verified from 33 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $976.2K | 22 | 65.7% |
| DR REDDYS LABORATORIES LIMITED | $360.4K | 8 | 24.2% |
| DR REDDY S LABORATORIES LIMITED | $150.0K | 3 | 10.1% |
WESTROCK sources Naproxen from 3 verified Indian suppliers based on 33 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 65.7% of imports.
How Does WESTROCK Compare to Nearest Naproxen Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | GLENMARK PHARMACEUTICALS INC USA | UNITED STATES | $1.8M | 35 | $50.0K |
| 19 | APOTEX INC | CANADA | $1.7M | 34 | $49.1K |
| 14 | WESTROCK ★ | UNITED STATES | $1.4M | 28 | $50.0K |
| 8 | DR REDDYS LABORATORIES INC | UNITED STATES | $1.1M | 23 | $50.0K |
| 11 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $950.0K | 19 | $50.0K |
WESTROCK ranks #14 among 366 Naproxen importers from India. Average shipment value of $50.0K compared to the market average of $141.4K. The closest competitors by value are GLENMARK PHARMACEUTICALS INC USA and APOTEX INC.
Where Does WESTROCK Import Naproxen To?
Destination countries from 33 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.4M | 32 | 96.6% |
| UNITED STATES OF AMERICA | $50.0K | 1 | 3.4% |
WESTROCK imports Naproxen to 2 countries. The primary destination is UNITED STATES receiving 96.6% of shipments worth $1.4M.
What Naproxen Formulations Does WESTROCK Import?
| Formulation | Value | Shipments |
|---|---|---|
| NAPROXEN SODIUM TABLETS USP 220MG 400 S | $281.6K | 7 |
| NAPROXEN SODIUM TABLETS USP 220MG 400S | $256.0K | 6 |
| NAPROXEN SODIUM TABLETS USP 220MG 400S (NSAID) (47775 X 400S PACKS=19110000 NOS)NOS | $144.3K | 3 |
| NAPROXEN SODIUM TABLETS USP 220MG 400S NSAID 50191 X 400S PACKS=20076400 NOS | $100.0K | 2 |
| NAPROXEN SODIUM TABLETS USP 220MG 400 S NSAID 24387 PACKS X 400 S 9754800 NOS | $50.0K | 1 |
| NAPROXEN SODIUM TABLETS USP 220MG 400S (NSAID) (49880 X 400 S PACKS = 19952000 NOS) | $50.0K | 1 |
| NAPROXEN SODIUM TABLETS USP 220MG 400S NSAID 50127 X 400 S PACKS = 20050800 NOS | $50.0K | 1 |
| NAPROXEN SODIUM TABLETS USP 220MG 400SNSAID 51441 X 400S PACKS=20576400 NOS | $50.0K | 1 |
| NAPROXEN SODIUM TABLETS USP 220MG 400S (NSAID) (51572 X 400S PACKS=20628800 NOS) | $50.0K | 1 |
| NAPROXEN SODIUM TABLETS USP 220MG (39450X 400's PACK = 15780000 NOS) | $50.0K | 1 |
WESTROCK imports 19 distinct Naproxen formulations from India. The top formulation is NAPROXEN SODIUM TABLETS USP 220MG 400 S with 7 shipments worth $281.6K.
Regulatory Requirements: Importing Naproxen into United States
What WESTROCK and other importers must comply with to import Naproxen from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Naproxen
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Naproxen from India and How Much Does WESTROCK Import?
India exported $51.8M worth of Naproxen through 3,414 shipments from 192 suppliers to 76 countries, serving 366 buyers globally. WESTROCK imports $1.5M of this total, accounting for 1.2% of India's Naproxen exports with 33 shipments from UNITED STATES. This is verified from 33 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for WESTROCK's Naproxen Imports?
WESTROCK's average Naproxen order value is $45.0K per consignment, based on 33 shipments totaling $1.5M. WESTROCK is based in UNITED STATES and ranks #14 among all Naproxen importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Naproxen to WESTROCK?
WESTROCK sources Naproxen from 3 verified Indian suppliers: DR.REDDY'S LABORATORIES LIMITED ($976.2K, 65.7%), DR REDDYS LABORATORIES LIMITED ($360.4K, 24.2%), DR REDDY S LABORATORIES LIMITED ($150.0K, 10.1%). This is based on 33 customs records.
How Does WESTROCK Compare to Other Naproxen Importers?
WESTROCK ranks #14 among 366 Naproxen importers from India with a 1.2% market share. The top 3 importers are GLENMARK PHARMACEUTICALS INC., USA ($11.0M), KRKA D.D., NOVO MESTO ($6.3M), APL SWIFT SERVICES (MALTA) LTD., ($5.2M). WESTROCK processed 33 shipments from UNITED STATES.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Naproxen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: WESTROCK matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as WESTROCK's capped import value divided by total capped export value for Naproxen across all Indian exporters.
- 5.Verified Records: This page is backed by 33 individual customs records matching WESTROCK importing Naproxen, covering 19 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 76+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Naproxen Import Data for WESTROCK
Access order-level details, pricing data, supplier connections, and competitive analysis for WESTROCK's Naproxen imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
WESTROCK
Company Profile
Multiple products · $0 total trade · Multiple categories
WESTROCK × Naproxen
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for WESTROCK.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Naproxen. For current order-level data, contact TransData Nexus.